Medical Condition News

RSS

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

A single-center observational study of more than 1,000 oncological examinations has demonstrated that positron emission tomography/magnetic resonance imaging (PET/MRI) facilitates cancer staging as well as PET/computed tomography (PET/CT) and improves lesion detectability in select cancers, potentially helping to promote fast, efficient local and whole-body staging in one step.

17 Sep 2020

CNIC researchers uncover a mechanism explaining how macrophages regulate obesity

Macrophages are immune system cells. They are essential in the early response to infections, and they also have a key role in the proper functioning of our tissues and the regulation of obesity.

17 Sep 2020

COVID-19 could be diagnosed using stroke scans

New research from King's College London has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke.

17 Sep 2020

Researchers secure NIH funding to study differences in glioblastoma between males and females

A team led by researchers from Case Western Reserve University School of Medicine and Cleveland Clinic Lerner Research Institute has secured $10.4 million over five years from the National Institutes of Health/National Cancer Institute to explore at the molecular level the differences in glioblastoma between males and females.

17 Sep 2020

Study finds potential target for migraine therapy

Migraines affect millions of people worldwide, often lasting days and severely disrupting lives. More than simply super-intense headaches, some migraines actually result from pathological excitation of neurons in the brain.

17 Sep 2020

Combined use of three drugs linked with lower lung cancer incidence and mortality

Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology.

17 Sep 2020

Smart drug delivery system may help treat spinal cord injuries, neurological disorders

A Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

17 Sep 2020

Medical robotic hand could allow doctors to assess vital diagnostic data

A medical robotic hand could allow doctors to more accurately diagnose and treat people from halfway around the world, but currently available technologies aren't good enough to match the in-person experience.

17 Sep 2020

Higher viral loads can increase mortality rate in patients hospitalized with COVID-19 and cancer

Higher viral loads are associated with a greater risk of death among cancer and non-cancer patients hospitalized with coronavirus disease 2019 (COVID-19), researchers report September 15 in the journal Cancer Cell.

17 Sep 2020

Salk institute to establish world-class consortium to study cellular and tissue aging in humans

The Salk Institute will establish a world-class San Diego Nathan Shock Center (SD-NSC), a consortium with Sanford Burnham Prebys Medical Institute (SBP) and the University of California San Diego (UC San Diego), to study cellular and tissue aging in humans.

17 Sep 2020

Study shows how the body's immune system finds intruding or damaged cells

Research led by Dr. Wonmuk Hwang has led to better understanding on how components of the body's immune system find intruding or damaged cells, which could lead to novel approaches to viral and cancer treatments.

17 Sep 2020

Researchers develop new strategy to mimic heart-regenerating effects of cardiac cell transplants

Ling Gao and colleagues have developed a strategy that uses exosomes - tiny membrane-bound sacs secreted by cells - to mimic the heart-regenerating effects of cardiac cell transplants, while potentially avoiding risks associated with whole-cell transplants.

17 Sep 2020

Effective interventions needed for increasing CRC screening among African-American men

Out of any other racial group, African American men have the lowest five-year survival rate for colorectal cancer (CRC).

16 Sep 2020

Point-of-care biomarker assay predicts traumatic brain injury in minutes

Intracranial abnormalities on CT scan in patients with traumatic brain injury (TBI) can be predicted by glial fibrillary acidic protein (GFAP) levels in the blood.

16 Sep 2020

A ferry protein in the pancreas safeguards beta-cells from high-fat diet induced stress

Every time we eat, the glucose level in our body goes up. This spurs our pancreatic machinery into action and through intricate physiological mechanisms, appropriate amounts of insulin are produced, our blood glucose levels are controlled, and we remain healthy.

16 Sep 2020

Researchers uncover how vitamin E acetate might cause lung injury in vapers

E-cigarette, or vaping, associated lung injury (EVALI) has sickened thousands of people, most under the age of 35.

16 Sep 2020

Kessler Foundation tests digital therapeutic device to improve mobility after stroke

Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.

16 Sep 2020

Pollution exposure associated with stroke risk in people with atrial fibrillation

People with one of the most common heart disorders who are exposed to greater levels of pollution have a 1.2-fold higher risk of stroke than their peers who live with less pollution, according to a JAMA Network Open study published recently by researchers at the UPMC Heart and Vascular Institute and University of Pittsburgh School of Medicine.

16 Sep 2020

UC Davis uses microneedles to deliver gene therapy for retinal diseases

A novel approach to delivering gene therapy for retinal diseases eliminates the need for complex eye surgery and treats more damaged cells than existing methods, a team of UC Davis physicians and veterinary eye specialists has found.

16 Sep 2020

First clinical trial launched to test psilocybin therapy for depression in cancer patients

The first clinical trial to test the safety and feasibility of psilocybin therapy with simultaneous administration and one-on-one patient support to treat depression in cancer patients was launched today by Maryland Oncology Hematology at the Aquilino Cancer Center at Adventist HealthCare Shady Grove Medical Center.

16 Sep 2020

Medical Condition News

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

CNIC researchers uncover a mechanism explaining how macrophages regulate obesity

COVID-19 could be diagnosed using stroke scans

Researchers secure NIH funding to study differences in glioblastoma between males and females

Study finds potential target for migraine therapy

Combined use of three drugs linked with lower lung cancer incidence and mortality

Smart drug delivery system may help treat spinal cord injuries, neurological disorders

Medical robotic hand could allow doctors to assess vital diagnostic data

Higher viral loads can increase mortality rate in patients hospitalized with COVID-19 and cancer

Salk institute to establish world-class consortium to study cellular and tissue aging in humans

Study shows how the body's immune system finds intruding or damaged cells

Researchers develop new strategy to mimic heart-regenerating effects of cardiac cell transplants

Effective interventions needed for increasing CRC screening among African-American men

Point-of-care biomarker assay predicts traumatic brain injury in minutes

A ferry protein in the pancreas safeguards beta-cells from high-fat diet induced stress

Researchers uncover how vitamin E acetate might cause lung injury in vapers

Kessler Foundation tests digital therapeutic device to improve mobility after stroke

Pollution exposure associated with stroke risk in people with atrial fibrillation

UC Davis uses microneedles to deliver gene therapy for retinal diseases

First clinical trial launched to test psilocybin therapy for depression in cancer patients

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News